The Archive · 2 posts
Driving innovation in precision medicine! 🚀 Diaceutics PLC (DXRX) revolutionises healthcare by boosting diagnostic testing strategies worldwide. 🌍
Diaceutics FY2025: revenue +20% to ÂŁ38.4m, returns to profitability, record ÂŁ38.9m order book. Strong growth and margins improving.
May 26, 2026
Showing 1 of 2 posts
Diaceutics FY 2024: 39% revenue surge & 50% EBITDA jump. US expansion, PMx adoption & enterprise deals fuel precision medicine dominance. Path to profit clear.
JoshuaMay 13, 2025